Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.
ABSTRACT: Background: Psoriasis is a chronic disease that has been associated not only with loss of work productivity and absenteeism, but also with disability, depression, and suicidal ideation in affected patients. The aim of this study was to evaluate the responsiveness of the Colombian Spanish v...
- Autores:
-
Berbeo Velásquez, Yusmay Katerine
Tibaduiza García, Maria Fernanda
- Tipo de recurso:
- Tesis
- Fecha de publicación:
- 2022
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/29690
- Acceso en línea:
- https://hdl.handle.net/10495/29690
- Palabra clave:
- Arthritis psoriatic
Biological therapy
Quality of life
Artritis psoriásica
Terapia biológica
Calidad de vida
Responsiveness
Psoriasis
Dermatology life quality index (DLQI)
https://id.nlm.nih.gov/mesh/D015535
https://id.nlm.nih.gov/mesh/D001691
https://id.nlm.nih.gov/mesh/D011788
- Rights
- embargoedAccess
- License
- http://creativecommons.org/licenses/by-nc-sa/2.5/co/
id |
UDEA2_9f920f9ae4265cf886b0849cc2e67917 |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/29690 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
title |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
spellingShingle |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. Arthritis psoriatic Biological therapy Quality of life Artritis psoriásica Terapia biológica Calidad de vida Responsiveness Psoriasis Dermatology life quality index (DLQI) https://id.nlm.nih.gov/mesh/D015535 https://id.nlm.nih.gov/mesh/D001691 https://id.nlm.nih.gov/mesh/D011788 |
title_short |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
title_full |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
title_fullStr |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
title_full_unstemmed |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
title_sort |
Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy. |
dc.creator.fl_str_mv |
Berbeo Velásquez, Yusmay Katerine Tibaduiza García, Maria Fernanda |
dc.contributor.advisor.none.fl_str_mv |
Sanclemente Mesa, Gloria Aguirre Acevedo, Daniel Camilo |
dc.contributor.author.none.fl_str_mv |
Berbeo Velásquez, Yusmay Katerine Tibaduiza García, Maria Fernanda |
dc.subject.mesh.none.fl_str_mv |
Arthritis psoriatic Biological therapy Quality of life Artritis psoriásica Terapia biológica Calidad de vida |
topic |
Arthritis psoriatic Biological therapy Quality of life Artritis psoriásica Terapia biológica Calidad de vida Responsiveness Psoriasis Dermatology life quality index (DLQI) https://id.nlm.nih.gov/mesh/D015535 https://id.nlm.nih.gov/mesh/D001691 https://id.nlm.nih.gov/mesh/D011788 |
dc.subject.proposal.spa.fl_str_mv |
Responsiveness Psoriasis Dermatology life quality index (DLQI) |
dc.subject.meshuri.none.fl_str_mv |
https://id.nlm.nih.gov/mesh/D015535 https://id.nlm.nih.gov/mesh/D001691 https://id.nlm.nih.gov/mesh/D011788 |
description |
ABSTRACT: Background: Psoriasis is a chronic disease that has been associated not only with loss of work productivity and absenteeism, but also with disability, depression, and suicidal ideation in affected patients. The aim of this study was to evaluate the responsiveness of the Colombian Spanish version of DLQI instrument in patients with psoriasis who initiate treatment with biologic therapy. Methodology: Observational, descriptive, cross-sectional study based on retrospective data of patients with psoriasis treated in a referral center in the city of Medellin. Clinical and sociodemographic variables were collected, as well as patients' quality of life. The DLQI scale was applied before and 3 months after initiating biologic therapy. To assess the change between baseline and subsequent measurements, the effect size was determined with Cohen's d-test. Results: A total of 257 patients were included. Their mean age was 52.8 years. The main subtypes of psoriasis were chronic plaque psoriasis (88.3%), psoriatic arthropathy (33.5%). The subtypes with the highest baseline mean DLQI scores were pustular psoriasis (14.2), scalp psoriasis (6.81) and palmoplantar psoriasis (5.71). Most of the patients evaluated received treatment with anti-tumor necrosis factor drugs. Both the DLQI and PASI had lower mean scores throughout follow-up. The effect size obtained by Cohen's d-test, between baseline vs. first follow-up DLQI measurement after initiation of biologic therapy was mild for psoriasis classified as mild at baseline; however, the effect size was strong for patients who had severe psoriasis at their initial evaluation. Conclusions: The Colombian Spanish version of the Dermatological Quality of Life Index (DLQI) in patients with psoriasis has a low responsiveness even though the therapy implemented in these patients was effective. |
publishDate |
2022 |
dc.date.accessioned.none.fl_str_mv |
2022-07-12T19:06:03Z |
dc.date.available.none.fl_str_mv |
2022-07-12T19:06:03Z |
dc.date.issued.none.fl_str_mv |
2022 |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/other |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_b1a7d7d4d402bcce |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/draft |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_46ec |
dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/COther |
dc.type.local.spa.fl_str_mv |
Tesis/Trabajo de grado - Monografía - Especialización |
format |
http://purl.org/coar/resource_type/c_46ec |
status_str |
draft |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/29690 |
url |
https://hdl.handle.net/10495/29690 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/embargoedAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-sa/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_f1cf |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
eu_rights_str_mv |
embargoedAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/2.5/co/ http://purl.org/coar/access_right/c_f1cf https://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.format.extent.spa.fl_str_mv |
38 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.group.spa.fl_str_mv |
GRID - Grupo de Investigación Dermatológica |
dc.publisher.place.spa.fl_str_mv |
Medellín - Colombia |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/7/license_rdf https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/8/license.txt https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/6/BerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdf |
bitstream.checksum.fl_str_mv |
e2060682c9c70d4d30c83c51448f4eed 8a4605be74aa9ea9d79846c1fba20a33 fc601186fb52e018e67d2cd8279df0d1 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173145871745024 |
spelling |
Sanclemente Mesa, GloriaAguirre Acevedo, Daniel CamiloBerbeo Velásquez, Yusmay KaterineTibaduiza García, Maria Fernanda2022-07-12T19:06:03Z2022-07-12T19:06:03Z2022https://hdl.handle.net/10495/29690ABSTRACT: Background: Psoriasis is a chronic disease that has been associated not only with loss of work productivity and absenteeism, but also with disability, depression, and suicidal ideation in affected patients. The aim of this study was to evaluate the responsiveness of the Colombian Spanish version of DLQI instrument in patients with psoriasis who initiate treatment with biologic therapy. Methodology: Observational, descriptive, cross-sectional study based on retrospective data of patients with psoriasis treated in a referral center in the city of Medellin. Clinical and sociodemographic variables were collected, as well as patients' quality of life. The DLQI scale was applied before and 3 months after initiating biologic therapy. To assess the change between baseline and subsequent measurements, the effect size was determined with Cohen's d-test. Results: A total of 257 patients were included. Their mean age was 52.8 years. The main subtypes of psoriasis were chronic plaque psoriasis (88.3%), psoriatic arthropathy (33.5%). The subtypes with the highest baseline mean DLQI scores were pustular psoriasis (14.2), scalp psoriasis (6.81) and palmoplantar psoriasis (5.71). Most of the patients evaluated received treatment with anti-tumor necrosis factor drugs. Both the DLQI and PASI had lower mean scores throughout follow-up. The effect size obtained by Cohen's d-test, between baseline vs. first follow-up DLQI measurement after initiation of biologic therapy was mild for psoriasis classified as mild at baseline; however, the effect size was strong for patients who had severe psoriasis at their initial evaluation. Conclusions: The Colombian Spanish version of the Dermatological Quality of Life Index (DLQI) in patients with psoriasis has a low responsiveness even though the therapy implemented in these patients was effective.RESUMEN: Antecedentes: La psoriasis es una enfermedad crónica que no solo se ha relacionado con pérdida de productividad laboral y ausentismo, sino también con discapacidad, depresión e ideación suicida en los pacientes afectados. El objetivo de este estudio fue evaluar la sensibilidad al cambio del instrumento DLQI en su versión en español colombiano en pacientes con psoriasis que inician tratamiento con terapia biológica. Métodos: estudio observacional, descriptivo de corte transversal basado en datos retrospectivos de pacientes con psoriasis atendidos en un centro de referencia en la ciudad de Medellín. Se recolectaron variables clínicas y sociodemográficas, así como de calidad de vida de los pacientes. Se aplicó la escala DLQI antes y 3 meses después de iniciar la terapia biológica. Para valorar el cambio entre la medición basal y las mediciones posteriores, se determinó el tamaño del efecto con la prueba “d” de Cohen. Resultados: Se incluyeron 257 pacientes. Su edad media fue de 52.8 años. Los principales subtipos de psoriasis fueron la psoriasis en placas (88.3%), la artropatía psoriásica (33,5%). Los subtipos con mayores puntajes de DLQI promedio basal fueron la psoriasis pustulosa (14.2), psoriasis en cuero cabelludo (6.81) y la psoriasis palmoplantar (5.71). La mayoría de los pacientes evaluados recibieron tratamiento con medicamentos anti-factor de necrosis tumoral. Tanto el DLQI como el PASI tuvieron menores puntuaciones promedios a lo largo del seguimiento. El tamaño del efecto obtenido por la prueba de Cohen, entre la medición basal vs el primer seguimiento del DLQI luego de iniciada la terapia biológica fue leve en el caso de las psoriasis clasificadas como leves al inicio, sin embargo, el tamaño del efecto fue fuerte para pacientes que tuvieron psoriasis grave en su evaluación inicial. Conclusiones: La versión en Español Colombiano del Índice de Calidad de Vida Dermatológica (DLQI) en pacientes con psoriasis tiene una sensibilidad baja a pesar de que la terapia instaurada en estos pacientes si fue eficaz.38application/pdfenginfo:eu-repo/semantics/draftinfo:eu-repo/semantics/otherhttp://purl.org/coar/resource_type/c_46echttp://purl.org/redcol/resource_type/COtherTesis/Trabajo de grado - Monografía - Especializaciónhttp://purl.org/coar/version/c_b1a7d7d4d402bcceinfo:eu-repo/semantics/embargoedAccesshttp://creativecommons.org/licenses/by-nc-sa/2.5/co/http://purl.org/coar/access_right/c_f1cfhttps://creativecommons.org/licenses/by-nc-sa/4.0/Arthritis psoriaticBiological therapyQuality of lifeArtritis psoriásicaTerapia biológicaCalidad de vidaResponsivenessPsoriasisDermatology life quality index (DLQI)https://id.nlm.nih.gov/mesh/D015535https://id.nlm.nih.gov/mesh/D001691https://id.nlm.nih.gov/mesh/D011788Responsiveness of the Colombian Spanish version of the DLQI in patients with psoriasis who started treatment with biologic therapy.GRID - Grupo de Investigación DermatológicaMedellín - ColombiaEspecialista en dermatologíaEspecializaciónFacultad de Medicina. Especialización en DermatologíaUniversidad de AntioquiaCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81051https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/7/license_rdfe2060682c9c70d4d30c83c51448f4eedMD57LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/8/license.txt8a4605be74aa9ea9d79846c1fba20a33MD58ORIGINALBerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdfBerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdfTrabajo de grado de especializaciónapplication/pdf529450https://bibliotecadigital.udea.edu.co/bitstream/10495/29690/6/BerbeoKaterine_2022_SensibilidadDLQIPsoriasis.pdffc601186fb52e018e67d2cd8279df0d1MD5610495/29690oai:bibliotecadigital.udea.edu.co:10495/296902022-07-12 14:11:17.928Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |